TEVA News and Press, Teva Pharmaceutical Industries Limited American Depositary Shares From 02/05/26

2026-02-05 12:47:24 ET Harel Insurance Investments & Financial Services Ltd. disclosed in its Feb. 3, 2026, SEC filing that it sold 4,177,000 shares of the Invesco KBW Bank ETF (KBWB), an estimated $330 million transaction based on the quarterly average price. According to a filin...

Teva Canada Announces Approval of Expanded Indication of [Pr]AJOVY® (fremanezumab solution for subcutaneous injection), the First Anti-CGRP Preventive Treatment for Pediatric Episodic Migraine Canada NewsWire Health Canada approves Pr AJOVY® (fremanezumab solution for su...

2026-01-29 16:03:41 ET More on Teva Pharmaceutical Teva Pharmaceutical Industries Limited (TEVA) Q4 2025 Earnings Call Transcript Teva Pharmaceutical Industries Limited 2025 Q4 - Results - Earnings Call Presentation Teva Is No Longer A Turnaround Story; It's A Growth...

2026-01-29 11:04:39 ET from Scotiabank issued a price target of $40.00 for TEVA on 2026-01-29 15:18:14. The adjusted price target was set to $40.00. At the time of the announcement, TEVA was trading at $32.895. The overall price target consensus is at $36.83 with high pr...

2026-01-28 14:02:19 ET Teva Pharmaceutical Industries Limited (TEVA) Q4 2025 Earnings Call January 28, 2026 8:00 AM EST... Read the full article on Seeking Alpha For further details see: Teva Pharmaceutical Industries Limited (TEVA) Q4 2025 Earnings Call Transcript

2026-01-28 07:38:24 ET More on Teva Pharmaceutical Teva Is No Longer A Turnaround Story; It's A Growth One Teva Pharmaceutical Industries Limited (TEVA) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Teva Pharmaceutical Industries Limited (TEVA...

2026-01-28 07:36:43 ET More on Teva Pharmaceutical Teva Is No Longer A Turnaround Story; It's A Growth One Teva Pharmaceutical Industries Limited (TEVA) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Teva Pharmaceutical Industries Limited (TEVA...

2026-01-28 07:02:34 ET More on Teva Pharmaceutical Teva Is No Longer A Turnaround Story; It's A Growth One Teva Pharmaceutical Industries Limited (TEVA) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow Teva Pharmaceutical Industries Limited (TEVA...

Teva delivers 3 consecutive years of growth - 2025 revenues of $17.3 billion, an increase of 4% year-over-year (YoY) in U.S. dollars, or 3% in local currency (LC) terms, compared to 2024. Excluding Japan BV, revenues increased 5% YoY in LC. Key Innovative brands continued to drive growth ...

Microsoft Corporation (MSFT) is expected to report $3.88 for Q2 2026 LendingClub Corporation (LC) is expected to report $0.34 for Q4 2025 Beacon Financial Corporation (BBT) is expected to report $0.78 for Q4 2025 Century Communities Inc. (CCS) is expected to report $1.38 for Q4 2025 ...